Agenus Begins Dosing with Next-Gen Anti-CTLA-4 Antibody
Go back to Agenus Begins Dosing with Next-Gen Anti-CTLA-4 Antibody| AGENUS (NASDAQ: AGEN) | Delayed: 6.86 +0.36 (5.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.50 | 52 Week High | $7.49 | |||
| Open | $6.52 | 52 Week Low | $2.61 | |||
| Day High | $6.99 | P/E | N/A | |||
| Day Low | $6.51 | EPS | $-1.10 | |||
| Volume | 404,286 | |||||



